Literature DB >> 8918911

Characterization of the membrane association of the influenza virus matrix protein in living cells.

J Zhang1, R A Lamb.   

Abstract

To determine if membrane association is an intrinsic property of the influenza virus matrix protein (M1) it was expressed from cDNA in living cells in the absence of other influenza virus proteins. By using a membrane fractionation scheme the M1 protein was found to associate with membranes in a time-dependent manner (0 time = 45% total; after a 3-hr chase period = 68% total M1 protein). Coexpression of the integral membrane proteins HA+NA+M2 did not significantly increase the association of the M1 protein with cellular membranes, indicating that putative interactions of the M1 protein and the cytoplasmic tails of the integral membranes cannot be detected by this assay. Biochemical treatments of the M1 protein associated with membranes with alkali, high salt conditions, or Triton X-114 yielded data that challenge the normal criteria for integral membrane proteins or peripheral membrane proteins. Examination of the solubility of the M1 protein in influenza virus-infected cells to Triton X-100 extraction indicated it became increasingly insoluble with time, but the M1 protein could be solubilized in Triton X-100 containing 1 M NaCl, suggesting an association of the M1 protein with the cytoskeleton. However, when the M1 protein was expressed from cDNA, it did not become insoluble to Triton X-100 extraction, suggesting an interaction of the M1 protein unique to the influenza virus-infected cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918911     DOI: 10.1006/viro.1996.0599

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

1.  Influenza virus matrix protein is the major driving force in virus budding.

Authors:  P Gómez-Puertas; C Albo; E Pérez-Pastrana; A Vivo; A Portela
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  The packaging signal of influenza viral RNA molecules.

Authors:  S Tchatalbachev; R Flick; G Hobom
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

4.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

6.  Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability.

Authors:  Nina E Golantsova; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway.

Authors:  Larissa Kolesnikova; Sandra Bamberg; Beate Berghöfer; Stephan Becker
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

10.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.